Skip to main content

Annual Monitoring for Patients on Persistent Medications (MPM)

CBE ID
2371
1.4 Project
Patient Safety
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Fall 2018
Is Under Review
No
1.3 Measure Description

This measure assesses the percentage of patients 18 years of age and older who received a least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. Report the following three rates and a total rate:

- Rate 1: Annual Monitoring for patients on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB): At least one serum potassium and a serum creatinine therapeutic monitoring test in the measurement year.

- Rate 2: Annual monitoring for patients on diuretics: At least one serum potassium and a serum creatinine therapeutic monitoring test in the measurement year.

- Total rate (the sum of the two numerators divided by the sum of the two denominators)

    • 1.14 Numerator

      This measure is reported as two rates and a total rate.

      Rate 1: Annual monitoring for patients on ACE inhibitors or ARBs: the number of patients with at least one serum potassium and serum creatinine therapeutic monitoring test in the measurement year.



      Rate 2: Annual monitoring for patients on diuretics: the number of patients with at least one serum potassium and serum creatinine therapeutic monitoring test in the measurement year.

      Total rate: sum of the 2 numerators.

    • 1.15 Denominator

      Patients age 18 and older as of the end of the measurement year (e.g., December 31) who are on selected persistent medications (ACE Inhibitors/ARB or Diuretics.)

    • Exclusions

      Exclude patients who use hospice services or elect to use a hospice benefit any time during the measurement year, regardless of when the services began.

      Exclude patients who had an acute or nonacute inpatient encounter during the measurement year.

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Patient Safety Fall Cycle 2018
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      National Committee for Quality Assurance
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      © 2006 by the National Committee for Quality Assurance
      1100 13th Street, NW, Suite 1000
      Washington, DC 20005